• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Quest Diagnostics (NY:DGX)

    177.72 -0.42 (-0.24%)
    Streaming Delayed Price Updated: 12:33 PM EST, Jan 8, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Quest Diagnostics

    < Previous 1 2 Next >
    News headline image
    Guardant Health and Quest Diagnostics Announce Strategic Collaboration to Broaden Access to Guardant’s Shield™ Blood-based Screening Test in the United States
    From Guardant Health, Inc.
    Via Business Wire
    News headline image
    WHOOP to Bring Clinical Lab Testing from Quest Diagnostics to the WHOOP App
    From WHOOP
    Via Business Wire
    News headline image
    Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test
    Quest to Support Mainz Biomed’s ReconAAsense FDA Study and Has Option to Commercialize Test Kit Assuming FDA Approval 
    From Mainz BioMed NV
    Via GlobeNewswire
    News headline image
    Making Connections To Care: Quest Supports Inspiring Health Equity Event Hosted by Sisters on the Vineyard
    Via ACCESSWIRE
    News headline image
    Haystack Oncology and Lisata Therapeutics Initiate Research Collaboration to Use the Haystack MRD™ Technology to Evaluate Efficacy of Pancreatic Cancer Therapy
    From Lisata Therapeutics, Inc.; Quest Diagnostics, Haystack Oncology
    Via GlobeNewswire
    News headline image
    Myriad Genetics Sees Stock Surge with Hereditary Cancer Tests
    Myriad Genetics Inc. (NASDAQ: MYGN) is a leader in genetic testing and precision medicine. The company offers a wide variety of genetic tests including 
    Via MarketBeat
    Intelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX
    Via AB Newswire
    News headline image
    LifeMD Shares Come Back to Life on GLP-1 Business Growth
    LifeMD stock is surging as the company is riding the GLP-1 trend to double-digit revenue growth and projections for 67% earnings growth in 2024 
    Via MarketBeat
    News headline image
    Quest Diagnostics and Ultima Collaborate to Scale Ultima’s Technology in Fast-Growing Minimal Residual Disease and Whole Genome Sequencing
    From Ultima Genomics
    Via Business Wire
    Quest Diagnostics Inc. (NYSE: DGX) Highlighted for Surprising Price Action
    Via Investor Brand Network
    News headline image
    Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030
    EQNX::TICKER_START (OTCQB:TDSGF),(TSXV:TELO),(NASDAQ:GH),(NASDAQ:NTRA),(NYSE:DGX),(NASDAQ:NEO) EQNX::TICKER_END 
    Via FinancialNewsMedia
    News headline image
    Exact Sciences Serves Investors Exactly What They Wished For
    Diagnostic and cancer test products provider Exact Sciences Corp. (NASDAQ: EXAS) saw its shares spike over 17% on its Q1 2023 earnings results. The 
    Via MarketBeat
    News headline image
    UiPath is a Cheaper and More Profitable AI Stock
    With the mainstream popularity of ChatGPT, artificial intelligence (AI) has been all the rage in 2023. The AI wars between Microsoft Co. (NASDAQ: MSFT) invest 
    Via MarketBeat
    Topics Artificial Intelligence
    Quest Diagnostics Inc. (NYSE: DGX) Making Surprising Moves in Friday Session
    Via Investor Brand Network
    News headline image
    DermTech and Sonora Quest Laboratories Expand Access to Innovative Melanoma Detection Test
    From DermTech, Inc.
    Via Business Wire
    News headline image
    Here’s Why Quest Diagnostics Stock Should Be in Your Portfolio
    Medical diagnostic lab company Quest Diagnostic (NYSE: DGX) stock has been trading within a boxed range from $126 to $146 for the majority of 2022. 
    Via MarketBeat
    News headline image
    Achievers and Quest Diagnostics Win Gold in the 2022 Brandon Hall Group Excellence Technology Awards
    From Achievers
    Via Business Wire
    News headline image
    Rite Aid and Quest Diagnostics Expand Access to COVID-19 PCR Testing Nationwide
    From Rite Aid Corporation
    Via Business Wire
    News headline image
    Quest Diagnostics CHRO Receives "CHRO Lifetime Achievement Award"
    SOURCE: Quest Diagnostics 
    Via 3BL Media
    ConferMED Awarded Grant From the Quest Diagnostics Foundation To Provide Specialty eConsults to Front Line Providers at Federally Qualified Health Centers in Key Regions
    SOURCE: Quest Diagnostics 
    Via 3BL Media
    News headline image
    Quest for Health Equity Offers No Cost Wellness Screenings at Baltimore Community Event
    SOURCE: Quest Diagnostics 
    Via 3BL Media
    News headline image
    Quest Diagnostics Incorporated (NYSE:DGX) Shareholder Notice: Investigation over Potential Wrongdoing ↗
    San Diego, CA -- (SBWIRE) -- 05/12/2022 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Quest Diagnostics Incorporated. 
    Via SBWire
    Quest Diagnostics Announces Organizational Changes to Accelerate Growth and Drive Operational Excellence
    SOURCE: Quest Diagnostics 
    Via 3BL Media
    News headline image
    Quest Diagnostics Incorporated (NYSE:DGX) Investor Notice: Investigation over Possible Securities Laws Violations ↗
    San Diego, CA -- (SBWIRE) -- 03/23/2022 -- Quest Diagnostics Incorporated was under investigation over potential securities laws violations in connection with certain financial statements. 
    Via SBWire
    FORTUNE Magazine Names Quest Diagnostics One of 2022 "World's Most Admired Companies" For Eighth Consecutive Year
    SOURCE: Quest Diagnostics 
    Via 3BL Media
    Development of Novel Innovative Diagnostic tests Generating Huge Revenue Opportunity for Global Blood Testing Market
    Palm Beach, FL – February 16, 2022 – FinancialNewsMedia.com News Commentary – The global blood testing market has grown during the pandemic and is expected to continue to rise in the coming years.... 
    Via FinancialNewsMedia
    Walmart and Quest Diagnostics Empower People to Take Control of Their Healthcare Through New Consumer-Initiated Laboratory Testing Solution Powered by QuestDirect™ Through Walmart.com
    SOURCE: Quest Diagnostics 
    Via 3BL Media
    Quest Diagnostics Receives Perfect Score on Human Rights Campaign Foundation's Corporate Equality Index for Sixth Consecutive Year
    SOURCE: Quest Diagnostics 
    Via 3BL Media
    Project HOPE Awarded Grant to Reduce Transmission of COVID-19 Variants in Long-term Care Facilities
    SOURCE: Quest Diagnostics 
    Via 3BL Media
    Quest Diagnostics Earns Gold Status in American Heart Association's 2021 Workplace Health Achievement Index
    SOURCE: Quest Diagnostics 
    Via 3BL Media
    < Previous 1 2 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.